P. Mbelele

发表

Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania

S. Niemann, E. Houpt, S. Heysell, 2022, JAC-antimicrobial resistance.

Meta-Narrative Review of Molecular Methods for Diagnosis and Monitoring of Multidrug-Resistant Tuberculosis Treatment in Adults

S. Heysell, S. Mpagama, S. Mfinanga, 2018, International journal of mycobacteriology.

Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania

R. Kazwala, E. Komba, S. Mpagama, 2022, PloS one.

Levofloxacin pharmacokinetics in saliva as measured by a mobile microvolume UV spectrophotometer among people treated for rifampicin-resistant TB in Tanzania

S. Heysell, D. Touw, J. Alffenaar, 2021, The Journal of antimicrobial chemotherapy.

Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania

S. Gillespie, S. Heysell, B. Mtafya, 2021, Journal of Clinical Microbiology.

Clinical outcomes of new algorithm for diagnosis and treatment of Tuberculosis sepsis in HIV patients

S. Heysell, S. Mpagama, C. Moore, 2019, International journal of mycobacteriology.

Risk factors associated with multidrug resistant tuberculosis among patients referred to Kibong ’ oto Infectious Disease Hospital in northern Tanzania

M. Majigo, M. Matee, A. Abade, 2016 .

Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease

S. Gillespie, S. Heysell, D. Sloan, 2022, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Deploying a novel tuberculosis molecular bacterial load assay to assess the elimination rate of Mycobacterium tuberculosis in patients with multidrug-resistant tuberculosis in Tanzania

S. Gillespie, S. Heysell, B. Mtafya, 2020, bioRxiv.

Blood cytokine responses to early secreted protein antigen-6/culture filtrate protein-10 tuberculosis antigens 2 months after antituberculosis treatment among patients with drug-susceptible pulmonary tuberculosis

J. Buza, S. Mpagama, E. Sauli, 2019, International journal of mycobacteriology.

The burden and determinants of post-TB lung disease.

M. Lesosky, K. Mortimer, S. Mpagama, 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Clinical-demographic markers for improving diabetes mellitus diagnosis in people with tuberculosis in Tanzania

I. Bygbjerg, S. Heysell, K. Ramaiya, 2022, BMC Infectious Diseases.

Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation

S. Heysell, G. Kibiki, S. Mpagama, 2019, BMC Public Health.

Multiple Pathogens Contribute to Human Immunodeficiency Virus-Related Sepsis in Addition to Mycobacterium tuberculosis: A Prospective Cohort in Tanzania

S. Heysell, S. Mpagama, G. Shirima, 2022, International journal of mycobacteriology.

Whole-genome sequencing of SARS-CoV-2 isolates from symptomatic and asymptomatic individuals in Tanzania

G. Githinji, S. Heysell, S. Mpagama, 2023, Frontiers in Medicine.

Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring.

B. Sunguya, A. Hachiya, Y. Iwatani, 2019, The Journal of antimicrobial chemotherapy.

TB or not TB? Definitive determination of species within the M ycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug‐resistant tuberculosis

S. Heysell, S. Mpagama, K. Addo, 2021, Tropical medicine & international health : TM & IH.

TB or not TB? Deﬁnitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis

S. Heysell, S. Mpagama, K. Addo, 2021 .

Improved performance of Xpert MTB/RIF assay on sputum sediment samples obtained from presumptive pulmonary tuberculosis cases at Kibong’oto infectious diseases hospital in Tanzania

M. Matee, S. Mpagama, S. Aboud, 2017, BMC Infectious Diseases.

Factors associated with Partners Elicitation during HIV Index client’s testing in Dar es Salaam Region, Tanzania

G. Kwesigabo, A. Abade, Florence George Samizi, 2021, Journal of Interventional Epidemiology and Public Health.

Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania

T. Clark, H. Dockrell, S. Campino, 2020, BMC Genomics.

Pharmacodynamic Biomarkers for Quantifying the Mycobacterial Effect of High Doses of Rifampin in Patients with Rifampin-susceptible Pulmonary Tuberculosis

S. Heysell, G. Kibiki, R. Aarnoutse, 2021, International journal of mycobacteriology.

Impact of early diagnosis of impaired glucose regulation in tuberculosis: Comparison of clinical outcomes in people with tuberculosis in Tanzania

I. Bygbjerg, S. Heysell, K. Ramaiya, 2022, Tropical medicine & international health : TM & IH.

Predictors of a 30-day mortality following the first episode of stroke among patients admitted at referral hospitals in Dodoma, central Tanzania: A prospective longitudinal Observational Study

A. Baraka, P. Mbelele, A. Nyundo, 2023, medRxiv.

Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania

S. Heysell, D. Sloan, M. Boeree, 2023, Pilot and Feasibility Studies.

Phase 2b Open-label Randomized Controlled Trial to Evaluate the Efficacy, Safety and Tolerability of N-acetylcysteine in Reducing Adverse Drug Reactions among Adults Treated for Multidrug-resistant Tuberculosis in Tanzania. (Trial Acronym NAC Trial).

S. Heysell, G. Kibiki, D. Sloan, 2021 .

TB or not TB? Definitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis

S. Heysell, S. Mpagama, S. Mfinanga, 2022 .